These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 30450660

  • 1. Localized primary malignant pericardial mesothelioma.
    Song G, Bi W, Zhang X, Huang W, Zhou K, Ren W.
    J Clin Ultrasound; 2019 Mar; 47(3):178-181. PubMed ID: 30450660
    [Abstract] [Full Text] [Related]

  • 2. Malignant pericardial mesothelioma: diagnostic clues in multimodality imaging.
    Kim DY, Yoon YN, Hong GR, Ha JW, Shim CY.
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1385. PubMed ID: 32253564
    [No Abstract] [Full Text] [Related]

  • 3. Sarcomatoid Type Primary Pericardial Mesothelioma with a Long-term Survival after the Onset of Cardiac Tamponade.
    Saisho C, Ishii H, Edakuni N, Imamura Y, Tokito T, Kinoshita T, Azuma K, Yamada K, Hoshino T.
    Intern Med; 2016 Jul; 55(21):3161-3164. PubMed ID: 27803412
    [Abstract] [Full Text] [Related]

  • 4. [Primary mesothelioma of the pericardium].
    Cucchi G.
    Ital Heart J Suppl; 2003 Mar; 4(3):241-3. PubMed ID: 12784760
    [Abstract] [Full Text] [Related]

  • 5. Recurrence of Pericardial Mesothelioma Affecting the Myocardium After Pericardial Resection.
    Rodríguez M, Mallidi HR, da Silva A, Bueno R.
    Ann Thorac Surg; 2018 Nov; 106(5):e243-e245. PubMed ID: 29792828
    [Abstract] [Full Text] [Related]

  • 6. Neoplastic Pericardial Disease.
    Maleszewski JJ, Anavekar NS.
    Cardiol Clin; 2017 Nov; 35(4):589-600. PubMed ID: 29025549
    [Abstract] [Full Text] [Related]

  • 7. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial.
    Zalcman G, Mazieres J, Margery J, Greillier L, Audigier-Valette C, Moro-Sibilot D, Molinier O, Corre R, Monnet I, Gounant V, Rivière F, Janicot H, Gervais R, Locher C, Milleron B, Tran Q, Lebitasy MP, Morin F, Creveuil C, Parienti JJ, Scherpereel A, French Cooperative Thoracic Intergroup (IFCT).
    Lancet; 2016 Apr 02; 387(10026):1405-1414. PubMed ID: 26719230
    [Abstract] [Full Text] [Related]

  • 8. Endobronchial ultrasound-guided transbronchial needle aspiration in a patient with pericardial mesothelioma.
    Ashinuma H, Shingyoji M, Yoshida Y, Itakura M, Ishibashi F, Tamura H, Moriya Y, Itami M, Tatsumi K, Iizasa T.
    Intern Med; 2015 Apr 02; 54(1):43-8. PubMed ID: 25742892
    [Abstract] [Full Text] [Related]

  • 9. Diffuse Primary Malignant Pericardial Mesothelioma With Myocardial involvement: A Comprehensive Assessment Using Multimodel Echocardiography.
    Li Q, Qin Z, Sun D, Jiao N, Zhang H, Li Y, Xiao M, Ding M, Zhu F.
    Curr Probl Cardiol; 2022 Dec 02; 47(12):101356. PubMed ID: 36007620
    [Abstract] [Full Text] [Related]

  • 10. Report of a case of pericardial mesothelioma with liver metastases responding well to pemetrexed and platinum-based chemotherapy.
    Doval DC, Pande SB, Sharma JB, Rao SA, Prakash N, Vaid AK.
    J Thorac Oncol; 2007 Aug 02; 2(8):780-1. PubMed ID: 17762349
    [Abstract] [Full Text] [Related]

  • 11. Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial.
    Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, Mencoboni M, Planchard D, Chella A, Crinò L, Krzakowski M, Rüssel J, Maconi A, Gianoncelli L, Grosso F.
    Lancet Oncol; 2019 Dec 02; 20(12):1702-1709. PubMed ID: 31628016
    [Abstract] [Full Text] [Related]

  • 12. First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
    Fujimoto E, Kijima T, Kuribayashi K, Negi Y, Kanemura S, Mikami K, Doi H, Kitajima K, Nakano T.
    Expert Rev Anticancer Ther; 2017 Sep 02; 17(9):865-872. PubMed ID: 28594258
    [Abstract] [Full Text] [Related]

  • 13. Primary pericardial mesothelioma presenting as constrictive pericarditis.
    Oreopoulos G, Mickleborough L, Daniel L, De Sa M, Merchant N, Butany J.
    Can J Cardiol; 1999 Dec 02; 15(12):1367-72. PubMed ID: 10620743
    [Abstract] [Full Text] [Related]

  • 14. Long progression-free survival by pemetrexed continuation maintenance therapy following cisplatin-based chemotherapy in malignant pleural mesothelioma.
    Takeda T, Itano H, Fukita S, Saitoh M, Takeda S.
    Intern Med; 2014 Dec 02; 53(20):2347-51. PubMed ID: 25318801
    [Abstract] [Full Text] [Related]

  • 15. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.
    Nowak AK, Lesterhuis WJ, Kok PS, Brown C, Hughes BG, Karikios DJ, John T, Kao SC, Leslie C, Cook AM, Pavlakis N, Briscoe K, O'Byrne KJ, Karapetis CS, Lam WS, Langford A, Yip S, Stockler MR.
    Lancet Oncol; 2020 Sep 02; 21(9):1213-1223. PubMed ID: 32888453
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Metastatic mesothelioma of the pericardium].
    Kaden F.
    Z Kardiol; 1982 Jul 02; 71(7):485-7. PubMed ID: 7136142
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A Phase II Trial of First-Line Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Unresectable Malignant Pleural Mesothelioma: A Study Protocol.
    Fujimoto N, Aoe K, Kozuki T, Oze I, Kato K, Kishimoto T, Hotta K.
    Clin Lung Cancer; 2018 Sep 02; 19(5):e705-e707. PubMed ID: 29853412
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.